Zhejiang Langhua Pharmaceutical Co., ltd

About Zhejiang Langhua Pharmaceutical Co., ltd

Langhua Pharma,FDA, WHO, EDQM, ANVISA and NMPA approved manufacturer in China.Producing APIs, intermediates and Delivering CDMO projects. 
Robust GMP
Strong EHS
Experienced filing in the regulated markets.

Certifications
  • CN
  • 2015
    On CPHI since
  • 3
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
API Producer
Custom Manufacturing/Custom Synthesis
Contact info
Meet us at

CPHI North America 2024

Pennsylvania Convention Center, Philadelphia
07 May 2024 - 09 May 2024

CPHI & PMEC China 2024

Shanghai New International Expo Center
19 - 21 June 2024

Products from Zhejiang Langhua Pharmaceutical Co., ltd (5)

  • Spironolactone

    Product Spironolactone

    cardiovascular system drugs CEP and USDMF registered
  • Enrofloxacin

    Product Enrofloxacin

    Third generation Quinolones antibacterial products, veterinary use CEP and USDMF registered
  • Levofloxacin Hemihydrate

    Product Levofloxacin Hemihydrate

    Quinolones antibacterial product, anti-infective CEP , USDMF registered
  • Ciprofloxacin Hydrochloride

    Product Ciprofloxacin Hydrochloride

    Wide-range antibacterial
  • Canrenone

    Product Canrenone

    Intermediate grade: Assay: NLT 90%; NLT 97%. 
    API grade

Zhejiang Langhua Pharmaceutical Co., ltd Resources (2)